Reema A Patel
Overview
Explore the profile of Reema A Patel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
38
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Merkow R, Cavnar M, Gleisner A, Mayo S, Gholami S, Karanicolas P, et al.
Ann Surg Oncol
. 2025 Feb;
PMID: 39962001
Hepatic arterial infusion (HAI) pump chemotherapy is an effective therapy for colorectal liver metastases and intrahepatic cholangiocarcinoma. In the setting of recent reports suggesting favorable outcomes in these diseases with...
2.
Papke Jr D, Chrisinger J, French C, Crymes A, Krivak T, Estape R, et al.
Mod Pathol
. 2025 Feb;
38(5):100729.
PMID: 39921028
NUT fusion-associated cancers are heterogeneous and include NUT carcinoma and an emerging group with non-BRD4/BRD3/NSD3 fusion partners. In this study, we characterized 11 tumors harboring MAD::NUT fusions (10/11 in female...
3.
Selene I, Ozen M, Patel R
Semin Intervent Radiol
. 2024 Mar;
41(1):56-62.
PMID: 38495258
Hepatocellular carcinoma (HCC) is a prevalent primary liver cancer, representing over 90% of cases globally and ranking as the third leading cause of cancer-related death. This article reviews the evolving...
4.
McDonald H, Zaki O, Wright M, Jayswal R, Weiss H, Nair R, et al.
Ann Surg Oncol
. 2023 Nov;
31(2):1252-1263.
PMID: 38006531
Background: Discontinuation of the Codman 3000 pump in 2018 left no Food and Drug Administration (FDA)-approved hepatic artery infusion (HAI) device for unresectable colorectal liver metastases (uCLM) and intrahepatic cholangiocarcinoma...
5.
Judge S, Ghalambor T, Cavnar M, Lidsky M, Merkow R, Cho M, et al.
Ann Surg Oncol
. 2023 Sep;
30(12):7362-7370.
PMID: 37702903
Background: An increasing number of hepatic artery infusion (HAI) programs have been established worldwide. Practice patterns for this complex therapy across these programs have not been reported. This survey aimed...
6.
McDonald H, Sarvestani A, Owen J, Rueckert J, Wierman M, Kiseljak-Vassiliades K, et al.
HPB (Oxford)
. 2023 Jul;
25(11):1446-1449.
PMID: 37453816
No abstract available.
7.
McDonald H, Harper M, Hill K, Gao A, Solomon A, Bailey C, et al.
Cancers (Basel)
. 2023 Jun;
15(11).
PMID: 37296998
Gastric adenocarcinoma (GAd) is the third leading cause of cancer-related deaths worldwide. Most patients require perioperative chemotherapy, yet methods to accurately predict responses to therapy are lacking. Thus, patients may...
8.
McDonald H, Patel R, Ellis C, Gholami S, Barry-Hundeyin M, Pandalai P, et al.
Surgery
. 2023 May;
174(1):101-105.
PMID: 37137740
Implementation of a successful hepatic artery infusion pump program requires numerous factors to be in place, and the lack of any of these may lead to program failure. First and...
9.
Ahmed T, Yadav R, Ul Abedin Z, Cao X, Dexter N, Patel R, et al.
Curr Probl Cardiol
. 2022 Dec;
48(4):101577.
PMID: 36584727
No abstract available.
10.
Choi M, Harper M, Pandalai P, Abdel-Misih S, Patel R, Ellis C, et al.
Ann Surg Oncol
. 2022 Nov;
30(2):804-813.
PMID: 36344711
Background: Nanoliposomal irinotecan (nal-IRI) is a promising novel hyperthermic intraperitoneal chemotherapy (HIPEC) agent given its enhanced efficacy against gastrointestinal tumors, safety profile, thermo-synergy, and heat stability. This report describes the...